Does GLUT-1 have a Role in Prognosis of Breast Carcinoma of Egyptian Patients?

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 8

Abstract

ABSTRACT Introduction: Breast Cancer (BC) is the most common malignancy in females worldwide. It constitutes 38.8% of all malignant tumours among Egyptian females. Triple negative breast cancer has not confirmed therapeutic molecular target and has a poor prognosis, so identification of new biological key pathways might aid in finding targets of potential interest for therapeutic blockade. Glucose transporter 1 (GLUT-1) has important role in the transport of glucose in malignant cells and overexpressed in different types of human cancers but its expression in breast carcinoma tissues is controversial. Aim: To evaluate the role of GLUT-1 in breast carcinoma in Egyptian patients. Materials and Methods: Retrospective study included 79 Invasive Duct Carcinoma (IDC) specimens retrieved from the archival cases of Pathology Department, faculty of medicine, Menoufia University, Egypt, spanning the period between January, 2010 and December, 2017. All cases were stained for GLUT-1 antibody. Results: Eighty percent of the studied IDC cases showed positive GLUT-1 expression, positive cases are divided into +1, +2 and +3 and 55% of positive cases were +3. There was a highly statistical significant association between positive GLUT-1 expression and advanced nodal stage (p=0.001) and advanced T stage (p=0.000). Furthermore, there was a highly statistical significant association between positive GLUT-1 expression and poor degree of differentiation (Grade III) (p=0.000). Moreover, there was a statistical significant association between (+3) GLUT-1 positivity and advanced stage (III and IV) (p=0.018). Also, there is a trend of significance between GLUT-1 expression and hormonal status as 94.1% of triple negative cases showed positive GLUT-1 expression (p=0.078). There was no statistical association between GLUT-1 expression and overall survival and univariate survival analysis revealed the bad prognostic impact of negative hormonal status (p=0.002). Conclusion: GLUT-1 is a poor prognostic marker in view of association between positive GLUT-1 expression and advanced nodal stage, advanced T stage, advanced stage grouping (III and IV) and poor degree of differentiation (Grade). Furthermore, inhibition of GLUT-1 might play a therapeutic role for triple negative breast cancer.

Authors and Affiliations

Mohammed Abo El-fotoh Shehata, Nanis Shawky Holah, Suzan El-hassanin, Suzy Gohar, Yaser Helmy

Keywords

Related Articles

Single Loading Low Dose MgSo4 Regimen: A Simple, Safe and Effective Alternative to Pritchard’s Regimen for Indian Women

Introduction: Magnesium sulphate is the anticonvulsant of choice in prevention and control of eclamptic convulsions. Pritchard’s regimen is the most popular time-tested regimen used. However, owing to concerns of toxicit...

Various Clinical and Histopathological Patterns of Idiopathic Photodermatosis: An Observational Study

ABSTRACT Introduction: The idiopathic photodermatosis have different histopathological patterns, spongiotic pattern being the most common. Aim: To study the histopathological patterns of photodermatosis and to correlate...

Evaluation of DNA Damage in Type 1 Diabetes Patients

ABSTRACT Introduction: DNA damage due to oxidative stress leads to progression of diabetic complications. The association between DNA damage and diabetes mellitus has prompted to study the extent of DNA damage and factor...

Prinzmetals Angina Masquerading as Acute Pericarditis

Coronary artery spasm is an intense vasoconstriction of the coronary arteries and may be responsible for the myocardial ischemia, myocardial infarction as well as sudden deaths. Coronary angiography is generally needed t...

Download PDF file
  • EP ID EP523914
  • DOI 10.7860/JCDR/2018/36450.11942
  • Views 80
  • Downloads 0

How To Cite

Mohammed Abo El-fotoh Shehata, Nanis Shawky Holah, Suzan El-hassanin, Suzy Gohar, Yaser Helmy (2018). Does GLUT-1 have a Role in Prognosis of Breast Carcinoma of Egyptian Patients?. Journal of Clinical and Diagnostic Research, 12(8), 5-9. https://www.europub.co.uk/articles/-A-523914